Optimind Pharma Corp. (CSE:OMND)
Canada flag Canada · Delayed Price · Currency is CAD
0.0050
0.00 (0.00%)
Aug 5, 2025, 1:15 PM EDT

Paramount Global Revenue

Optimind Pharma had revenue of 35.71K CAD in the quarter ending May 31, 2025, with 122.47% growth. This brings the company's revenue in the last twelve months to 138.02K, up 41.22% year-over-year. In the fiscal year ending February 28, 2025, Optimind Pharma had annual revenue of 118.37K, down -3.73%.

Revenue (ttm)
138.02K
Revenue Growth
+41.22%
P/S Ratio
3.74
Revenue / Employee
n/a
Employees
n/a
Market Cap
515.74K

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Feb 28, 2025118.37K-4.59K-3.73%
Feb 29, 2024122.96K-47.15K-27.72%
Feb 28, 2023170.11K70.42K70.64%
Feb 28, 202299.69K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition